Literature DB >> 17346923

Glutathione transferases in hepatocyte-like cells derived from human embryonic stem cells.

Therese Söderdahl1, Barbara Küppers-Munther, Nico Heins, Josefina Edsbagge, Petter Björquist, Ian Cotgreave, Bengt Jernström.   

Abstract

Human embryonic stem cells (hESCs) offer a potential unlimited source for functional human hepatocytes, since hESCs can differentiate into hepatocyte-like cells displaying a characteristic hepatic morphology and expressing several hepatic markers. These hepatocyte-like cells could be used in various human in vitro hepatocyte assays, e.g. as a test system for studying drug metabolism and drug-induced hepatotoxicity. Since the toxic effect of a compound is commonly dependent on biotransformation into metabolites, the presence of drug metabolising enzymes in potential test systems must be evaluated. We have investigated the presence of glutathione transferases (GSTs) in hepatocyte-like cells by immunocytochemistry and Western blotting. Results show that these cells have high levels of GSTA1-1, whereas GSTP1-1 is not present in most cases. GSTM1-1 is detected by immunocytochemistry but not by Western blotting. In addition, GST activity is detected in hepatocyte-like cells at levels comparable to human hepatocytes. These results indicate that the hepatocyte-like cells have characteristics that closely resemble those of human adult hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346923     DOI: 10.1016/j.tiv.2007.01.021

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  14 in total

Review 1.  Stem cells and stem cell-derived tissues and their use in safety assessment.

Authors:  Kyle Kolaja
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 2.  The possible use of stem cells in regenerative medicine: dream or reality?

Authors:  Sabrina Ehnert; Matthias Glanemann; Andreas Schmitt; Stephan Vogt; Naama Shanny; Natascha C Nussler; Ulrich Stöckle; Andreas Nussler
Journal:  Langenbecks Arch Surg       Date:  2009-07-31       Impact factor: 3.445

Review 3.  Stem cell-derived liver cells for drug testing and disease modeling.

Authors:  Matthew D Davidson; Brenton R Ware; Salman R Khetani
Journal:  Discov Med       Date:  2015-05       Impact factor: 2.970

Review 4.  Present state and future perspectives of using pluripotent stem cells in toxicology research.

Authors:  Anna M Wobus; Peter Löser
Journal:  Arch Toxicol       Date:  2011-01-12       Impact factor: 5.153

5.  Gene expression pattern of some classes of cytochrome P-450 and glutathione S-transferase enzymes in differentiated hepatocytes-like cells from menstrual blood stem cells.

Authors:  Aida Esmaeili-Rad; Sayeh Khanjani; Hamidreza Vaziri; Somaieh Kazemnejad
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-01-23       Impact factor: 2.416

6.  One Standardized Differentiation Procedure Robustly Generates Homogenous Hepatocyte Cultures Displaying Metabolic Diversity from a Large Panel of Human Pluripotent Stem Cells.

Authors:  Annika Asplund; Arvind Pradip; Mariska van Giezen; Anders Aspegren; Helena Choukair; Marie Rehnström; Susanna Jacobsson; Nidal Ghosheh; Dorra El Hajjam; Sandra Holmgren; Susanna Larsson; Jörg Benecke; Mariela Butron; Annelie Wigander; Karin Noaksson; Peter Sartipy; Petter Björquist; Josefina Edsbagge; Barbara Küppers-Munther
Journal:  Stem Cell Rev Rep       Date:  2016-02       Impact factor: 5.739

7.  Preferential glutathione conjugation of a reverse diol epoxide compared to a bay region diol epoxide of phenanthrene in human hepatocytes: relevance to molecular epidemiology studies of glutathione-s-transferase polymorphisms and cancer.

Authors:  Stephen S Hecht; Jeannette Zinggeler Berg; J Bradley Hochalter
Journal:  Chem Res Toxicol       Date:  2009-03-16       Impact factor: 3.739

Review 8.  Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet?

Authors:  Richard Kia; Rowena L C Sison; James Heslop; Neil R Kitteringham; Neil Hanley; John S Mills; B Kevin Park; Chris E P Goldring
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

Review 9.  Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury.

Authors:  Christopher Goldring; Daniel J Antoine; Frank Bonner; Jonathan Crozier; Chris Denning; Robert J Fontana; Neil A Hanley; David C Hay; Magnus Ingelman-Sundberg; Satu Juhila; Neil Kitteringham; Beatriz Silva-Lima; Alan Norris; Chris Pridgeon; James A Ross; Rowena Sison Young; Danilo Tagle; Belen Tornesi; Bob van de Water; Richard J Weaver; Fang Zhang; B Kevin Park
Journal:  Hepatology       Date:  2016-11-30       Impact factor: 17.425

10.  MicroRNA-122: a novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity.

Authors:  Richard Kia; Lorna Kelly; Rowena L C Sison-Young; Fang Zhang; Chris S Pridgeon; James A Heslop; Pete Metcalfe; Neil R Kitteringham; Melissa Baxter; Sean Harrison; Neil A Hanley; Zoë D Burke; Mike P Storm; Melanie J Welham; David Tosh; Barbara Küppers-Munther; Josefina Edsbagge; Philip J Starkey Lewis; Frank Bonner; Ernie Harpur; James Sidaway; Joanne Bowes; Stephen W Fenwick; Hassan Malik; Chris E P Goldring; B Kevin Park
Journal:  Toxicol Sci       Date:  2014-12-18       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.